NEWS COMMENTARY

BlueNalu forms alliance with Nutreco

Published:
January 20, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Partnership
by Thomas Hayes
Low importance

This is the first time a player solely focused on animal feed and nutrition has engaged with a cellular agriculture startup. Given the focus on aquaculture from both BlueNalu and Nutreco, a pairing makes sense, but the press release was scarce on details regarding what the two actually plan to work on together. BlueNalu did state, however, that it plans to release seafood products in a test market within the next two years. This comes a month after the company announced its development of a whole-muscle yellowtail fish fillet. Stay tuned for an upcoming Analyst Insight where we'll provide an update on these events and more in the rapidly evolving cellular agriculture space.

For the original news article, click here .


Further Reading

The latest synbio buzz: bee-free honey

News Commentary | October 09, 2020

Berkeley spinout MeliBio, backed by Big Idea Ventures, uses synbio to replicate the bioprocess bees use to make honey from nectar, but in an industrial bioreactor. While threats to bee populations might make alternatives to honey attractive or even necessary, normal honey production itself doesn't ... Not part of subscription

Sulfoxaflor will not remain in U.S. markets following federal court ruling

News Commentary | January 13, 2021

The Ninth Circuit U.S. Court of Appeals ruling found that the U.S. Environmental Protection Agency's 2010 re‑registration was based on flawed and limited data. Therefore, use will be postponed while the agency determines the effect(s) of sulfoxaflor on endangered species, including pollinators, data... Not part of subscription

Zymergen plunges 68% – materials development hard as usual

News Commentary | August 06, 2021

Zymergen went public on Earth Day this year and promised to generate sales of its first product, Hyaline, in H2 2021. Now it has pushed the target to 2022, and apparently, the public market has not responded well. As discussed in the key issue section of Genomatica's profile, Zymergen is essentially... To read more, click here.